Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation

被引:7
|
作者
Li, Yuehua [1 ,2 ]
Jiang, Baohong [3 ]
Zeng, Lijun [2 ]
Tang, Yuanbin [2 ]
Qi, Xiaowen [2 ]
Wan, Zhixing [2 ]
Feng, Wenjie [2 ]
Xie, Liming [2 ]
He, Rongfang [4 ]
Zhu, Hongbo [2 ]
Wu, Yimou [1 ]
机构
[1] Univ South China, Inst Pathogen Biol, Hengyang Med Sch, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Affiliated Hosp 1, Dept Med Oncol, Hengyang 421001, Hunan, Peoples R China
[3] Univ South China, Affiliated Hosp 1, Dept Pharm, Hengyang 421001, Hunan, Peoples R China
[4] Univ South China, Affiliated Hosp 1, Dept Pathol, Hengyang 421001, Hunan, Peoples R China
基金
中国博士后科学基金;
关键词
Triple-negative breast cancer; Environmental factors; Exosomes; CircCRIM1; OGA; Immune infiltration; CHEMOTHERAPY; METASTASIS; TRIAL; RNA;
D O I
10.1016/j.envres.2023.117266
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Triple-negative breast cancer (TNBC) has an escalating morbidity and a dismal prognosis. Obesity has been reported to be strongly linked to adverse TNBC outcomes. Exosomes (Exos) transport RNA and proteins between cells and serve as intermediaries for cell-to-cell communication. Accumulated evidence suggests that adiposesecreted circular RNAs (circRNAs) can modulate protein glycosylation in TNBC to facilitate tumor cell outgrowth. Herein, exo-circCRIM1 expression was found to be elevated in TNBC patients with a high body fat percentage. Functional experiments demonstrated that by inhibiting miR-503-5p, exo-circCRIM1 enhanced TNBC evolution and metastasis while activating glycosylation hydrolase OGA. Furthermore, OGA negatively regulates FBP1 by decreasing its protein stability. Moreover, the levels of OGA and FBP1 were positively related to the infiltration level of some immune cells in TNBC. These findings indicate that exo-cirCRIM1 secreted by adipocytes contributes to TNBC progression by inhibiting miR-503-5p and activating the OGA/FBP1 signaling pathway. The findings reveal a novel intercellular signaling pathway mediated by adipose-derived exosomes and suggest that treatment targeting the secreted exosome-circCRIM1 may reverse TNBC progression.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes
    Jafari, Naser
    Kolla, Manohar
    Meshulam, Tova
    Shafran, Jordan S.
    Qiu, Yuhan
    Casey, Allison N.
    Pompa, Isabella R.
    Ennis, Christina S.
    Mazzeo, Carla S.
    Rabhi, Nabil
    Farmer, Stephen R.
    Denis, Gerald, V
    SCIENCE SIGNALING, 2021, 14 (710)
  • [2] Adipocyte-Derived Exosomes as New Adipokines Sustaining Breast Cancer Progression
    Giordano, C.
    La Camera, G.
    Gelsomino, L.
    Barone, I.
    Panza, S.
    De Rose, D.
    Naimo, D.
    Giordano, V.
    Bonofiglio, D.
    Ando, S.
    Catalano, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S84 - S85
  • [3] Adipocyte-Derived Fibroblasts Promote Tumor Progression and Contribute to the Desmoplastic Reaction in Breast Cancer
    Bochet, Ludivine
    Lehuede, Camille
    Dauvillier, Stephanie
    Wang, Yuan Yuan
    Dirat, Beatrice
    Laurent, Victor
    Dray, Cedric
    Guiet, Romain
    Maridonneau-Parini, Isabelle
    Le Gonidec, Sophie
    Couderc, Bettina
    Escourrou, Ghislaine
    Valet, Philippe
    Muller, Catherine
    CANCER RESEARCH, 2013, 73 (18) : 5657 - 5668
  • [4] Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy
    Huang, Renhong
    Wang, Zheng
    Hong, Jin
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    CELL DEATH & DISEASE, 2023, 14 (10)
  • [5] Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy
    Renhong Huang
    Zheng Wang
    Jin Hong
    Jiayi Wu
    Ou Huang
    Jianrong He
    Weiguo Chen
    Yafen Li
    Xiaosong Chen
    Kunwei Shen
    Cell Death & Disease, 14
  • [6] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [7] Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity
    La Camera, Giusi
    Gelsomino, Luca
    Malivindi, Rocco
    Barone, Ines
    Panza, Salvatore
    De Rose, Daniela
    Giordano, Francesca
    D'Esposito, Vittoria
    Formisano, Pietro
    Bonofiglio, Daniela
    Ando, Sebastiano
    Giordano, Cinzia
    Catalano, Stefania
    CANCER LETTERS, 2021, 521 : 155 - 168
  • [8] Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer
    Li, Sha
    Wu, Yijing
    Ding, Fei
    Yang, Jiapei
    Li, Jing
    Gao, Xihui
    Zhang, Chuan
    Feng, Jing
    NANOSCALE, 2020, 12 (19) : 10854 - 10862
  • [9] DLAT promotes triple-negative breast cancer progression via YAP1 activation
    Liu, Diya
    Wang, Xuehui
    Qian, Fengyuan
    Ye, Danrong
    Deng, Xiaochong
    Fang, Lin
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [10] RASAL2 activates RAC1 to promote triple-negative breast cancer progression
    Feng, Min F
    Bao, Yi
    Li, Zhimei
    Li, Juntao
    Gong, Min
    Lam, Stella
    Wang, Jinhua
    Marzese, Diego M.
    Donovan, Nicholas
    Tan, Ern Yu
    Hoon, Dave S. B.
    Yu, Qiang
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12): : 5291 - 5304